Filter
939
Filtered Results: 939
Text search:
pharmaceutical
industry
Featured
Recommendations
64
New Publications
227
Language
Document type
No document type
443
Studies & Reports
224
Guidelines
142
Strategic & Response Plan
53
Manuals
44
Fact sheets
11
Situation Updates
8
Training Material
4
Brochures
3
Resource Platforms
3
Infographics
2
Online Courses
2
Countries / Regions
India
53
Global
48
Kenya
44
South Africa
24
Ethiopia
23
Nepal
18
Nigeria
18
Ghana
16
Sierra Leone
16
Uganda
16
Bangladesh
14
Philippines
12
Zambia
12
Indonesia
11
Ukraine
10
Africa
10
Tanzania
10
Western and Central Europe
10
Syria
9
Zimbabwe
9
Latin America and the Carribbean
9
Namibia
9
Myanmar / Burma
9
Rwanda
8
Botswana
8
Lesotho
7
Malawi
7
West and Central Africa
7
South–East Asia Region
6
Mozambique
5
Cambodia
5
Eastern Europe
5
Asia
4
Venezuela
4
East and Southern Africa
4
Liberia
4
Eswatini/ Swaziland
4
Thailand
3
Papua New Guinea
3
Pakistan
3
China
2
Laos
2
Senegal
2
Burkina Faso
2
Afghanistan
2
USA
2
Haiti
2
Jordan
2
Congo, Democratic Republic of
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
South Sudan
2
Tajikistan
1
Colombia
1
Timor Leste/ East Timor
1
Benin
1
Chile
1
Cameroon
1
Iran
1
Albania
1
Kyrgyzstan
1
Guinea
1
Lithuania
1
Germany
1
Saudi Arabia
1
Western Pacific Region
1
Paraguay
1
North America
1
Turkmenistan
1
Japan
1
Denmark
1
Belgium
1
Maldives
1
United Kingdom
1
Argentina
1
Lebanon
1
Vietnam
1
Brazil
1
Moldova
1
Sri Lanka
1
Russia
1
Egypt
1
Sudan
1
Central African Republic
1
Mali
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
360
Clinical Guidelines
49
Public Health
47
Key Resources
40
Pharmacy & Technologies
18
Women & Child Health
12
Capacity Building
6
Annual Report MEDBOX
2
Toolboxes
AMR
132
Pharmacy
86
COVID-19
70
Planetary Health
43
Mental Health
42
HIV
35
Rapid Response
31
NCDs
28
Global Health Education
28
TB
23
Health Financing Toolbox
21
NTDs
20
Caregiver
18
Conflict
18
Ebola & Marburg
15
Specific Hazards
13
Refugee
4
Disability
3
Zika
3
Polio
3
Natural Hazards
2
Social Ethics
2
Cholera
1
Guidelines for Good Clinical Laboratory Practices (GCLP) outlines the principles and procedures to be followed by medical laboratories involved in clinical research and/or patient care so as to provide quality data which can be used for health research and patient treatment. As the use of laboratory...
Exciting new treatment approaches make the management of hepatitic C one of the most rapidly developing areas of medicine. The Flying Publisher short Guide to Hepatitis C is an up-to-date source of information for physicians, residents and advanced medical students.
Antibiotic resistance (ABR) particularly hits resource poor countries, and is fuelled by irrational antibiotic (AB) prescribing. We surveyed knowledge, attitudes and practices of AB prescribing among medical students and doctors in Kisangani, DR Congo.
Antimicrobials have been a critical public health tool since the discovery of penicillin in 1928, saving the lives of millions of people around the world. Today, however, the emergence of drug resistance is reversing the miracles of the past eighty years, with drug choices for the treatment of many ...
Antibiotics have been a critical public health tool since the discovery of Penicillin in 1928, saving the lives of millions of people around the world. In developing country like ours, where the burden of treatable disease is very high and access to health facilities and laboratories is difficult, a...
Reporting system for the general public - This document aims to provide practical guidelines on how to set up national systems for consumers to report adverse reactions to medicines. The purpose is to help countries set up a well-organized and effective consumer reporting system within their pharmac...
The safety of medicines in Zambia - why health workers need to take action | Produced by the National Pharmacovigilance Unit (NPVU)
Sci Rep. 2016; 6: 25920. Published online 2016 May 16. doi: 10.1038/srep25920
The present National action plan on antimicrobial resistance (AMR) with component of antimicrobial consumption (AMC) covering both human and agriculture sectors was developed based on the World Health Organization's (WHO) Global plan on AMR dated 2015. With the purpose to develop this plan, in May 2...
The Ebola outbreak that started in December 2013 became a public
health, humanitarian and socioeconomic crisis with a devastating
impact on families, communities and affected countries. It also served
as a reminder that the world, including WHO, is ill-prepared for a large
and sustained disease ...
Global Action Plan on Antimicrobial Resistance
recommended
The goal of the draft global action plan is to ensure, for as long as possible, continuity of successful treatment and prevention of infectious diseases with effective and safe medicines that are quality-assured, used in a responsible way, and accessible to all who need them.
Updated 25 January 2021
How to address the global crisis in antibiotic research and development.
The report includes a comprehensive summary and critical evaluation of recent initiatives to overcome the barriers to achieve sustainable access to antibiotics. As antibiotic resistance will continue to develop as long as we ...
The extensive use of antimicrobials in human and veterinary medicine in recent years has accelerated the emergence and spread of resistant microorganisms. This situation has been worsened by the lack of investment in developing new effective antibiotics. The severity of the consequences is clear to ...
21.12.2020
Available in English, Spanish, Italian and Portuguese
ICAAP12 Secretariat
Partners in population and development, Dhaka, Bangladesh June 2016
